Biopol Chemicals Q2 FY27 Share Price & Earnings Call Analysis
- Market cap
- ₹51 Cr
- P/E
- 5.66
- ROE
- 28.24%
- Price to sales
- 0.63
- Debt to equity
- 0.17
- 52W high / low
- ₹120 / ₹84.8
- EBITDA margin
- 16.58%
- Net profit margin
- 11.05%
- Promoter holding
- 65.81%
- Sales (last year)
- ₹81 Cr
Incorporated in 2023, Biopol Chemicals Limited is engaged in the manufacturing and distribution of specialty chemicals categorized into silicones, emulsifiers, biochemicals, and polyelectrolytes.[1]
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Peers
Chemicals & Petrochemicals companies ranked on guidance
| # | Company | Revenue guided | Margin guided | Market cap | P/E |
|---|---|---|---|---|---|
| 1 | 40%+ | Up 2%+ | ₹1,858 Cr | 25.8 | |
| 2 | 40%+ | Up 0–2% | ₹234 Cr | 3.0 | |
| 3 | 40%+ | Flat | ₹3,514 Cr | 4.3 | |
| 4 | 40%+ | Flat | ₹2,257 Cr | 30.0 | |
| 5 | 40%+ | Flat | ₹180 Cr | 11.9 | |
| 6 | 40%+ | Flat | ₹138 Cr | 15.1 |
Sign up free to see every company in the sector ranking and track Biopol Chemicals.
Pro shows every company guiding 40%+ revenue growth →Full Chemicals & Petrochemicals rankingFinancials of Biopol Chemicals
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Shareholder Pattern
Biopol Chemicals
Shareholding breakup across reporting periods.
| Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|
| Promoters + | 65.81% | 65.81% | 65.81% |
| FIIs + | 9.30% | 4.70% | 0.47% |
| DIIs + | 2.92% | 0.54% | 0.00% |
| Public + | 21.98% | 28.95% | 33.73% |
| No. of Shareholders | 228 | 368 | 631 |
Financials of Biopol Chemicals
Quarterly Results
Quarter-by-quarter operating performance
Financials of Biopol Chemicals
Profit & Loss
Annual income statement trend
| Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|
| Sales + | 25 | 49 | 81 | 95 |
| Sales growth | +94% | +65% | +44% | |
| Expenses + | 21 | 43 | 68 | 77 |
| Operating Profit | 4 | 7 | 13 | 17 |
| OPM % | 17% | 13% | 17% | 18% |
| Other Income + | 0 | 0 | 0 | 0 |
| Interest | 0 | 1 | 2 | 2 |
| Depreciation | 0 | 0 | 0 | 0 |
| Profit before tax | 4 | 6 | 12 | 15 |
| Tax % | 25% | 25% | 26% | |
| Net Profit + | 3 | 4 | 9 | 11 |
| EPS in Rs | 3.74 | 5.45 | 8.30 | 10.50 |
| Dividend Payout % | 0% | 0% | 0% |
Financials of Biopol Chemicals
Balance Sheet
Capital structure and asset base
| Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|
| Equity Capital | 8 | 8 | 11 | 11 |
| Reserves | 1 | 6 | 39 | 44 |
| Borrowings + | 4 | 8 | 8 | 18 |
| Other Liabilities + | 5 | 10 | 11 | 10 |
| Total Liabilities | 18 | 32 | 70 | 83 |
| Fixed Assets + | 0 | 0 | 14 | 14 |
| CWIP | 0 | 0 | 0 | 11 |
| Investments | 0 | 0 | 0 | 0 |
| Other Assets + | 17 | 31 | 55 | 58 |
| Total Assets | 18 | 32 | 70 | 83 |
Financials of Biopol Chemicals
Cash Flows
Operating, investing and financing cash movement
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Cash from Operating Activity + | -6 | -2 | -13 |
| Cash from Investing Activity + | -1 | -0 | -15 |
| Cash from Financing Activity + | 7 | 4 | 27 |
| Net Cash Flow | 0 | 1 | -1 |
| Free Cash Flow | -7 | -2 | -27 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | -141% | -30% | -93% |
Financials of Biopol Chemicals
Ratios
Working capital efficiency and return ratios
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Debtor Days | 145 | 124 | 125 |
| Inventory Days | 121 | 107 | 113 |
| Days Payable | 78 | 78 | 37 |
| Cash Conversion Cycle | 189 | 153 | 201 |
| Working Capital Days | 127 | 95 | 179 |
| ROCE % | 38% | 34% |
Continue your research
What Biopol Chemicals's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Unilex Colour &C (Q2 FY27)
685.02 lakhs (Consolidated) with a YoY increase of approximately 2.22% (Rs. Key results statement takeaways from Unilex Colour & Chemical Ltd's Q2 FY27 results
- Andhra Sugars (Q2 FY27)
3,276.52 lakhs (~5.5% increase) . Key results statement takeaways from Andhra Sugars Ltd's Q2 FY27 results statement — and how it ranks against sector peers.
- Shanti Inorganics (Q2 FY27)
54.02 crore (Rs. Key results statement takeaways from Shanti Inorganics Ltd's Q2 FY27 results statement — and how it ranks against sector peers.
- Prolife Industries (Q2 FY27)
Year-on-Year Change for PAT**: Specific YoY % change not provided; previous period PAT for the half year ended Sept 30, 2025 is not provided in the shared…